473
Participants
Start Date
October 31, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
tigecycline
every 12 hours IV (an initial dose of 100 mg followed by 50 mg every 12 hours)
ceftriaxone plus metronidazole
Ceftriaxone sodium 2 g once daily intravenously plus metronidazole 1 g to 2 g daily given in divided doses intravenously. Test article should be administered for a minimum of 4 days and up to 14 days at the discretion of the investigator.
Taipei
Taoyuan District
Taichung
Changhua
Manila
Quezon City
Quezon City
Geneva
Bern
Pietermaritzburg
Nambour
Odense
Lugano
Parow
Bellville
Kuilsriver
Zurich
Athens
Athens
Lahti
Genova
Lübeck
Brescia
Pavia
Madrid
Madrid
Murcia
Udine
Tampere
Istanbul
Vicenza
Bochum
Münster
Bilbao
Thessaloniki
Seinäjoki
Frankfurt
Heidelberg
Pierre-Bénite
Tübingen
Freiburg im Breisgau
Saint-Denis
New Delhi
Shanghai
Mumbai
Cairns
Parkville
Marseille
Nîmes
Leipzig
New Territories
Pokfulam
Riyadh
Tainan City
Hyderabad
Bhopal
Lucknow
Rome
Almada
Coimbra
Porto
Porto
Pretoria
Barcelona
Ankara
Stockport
Birmingham
Wigan
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY